Revvity (RVTY) Net Income Growth (3y) (2012 - 2026)
Revvity (RVTY) Net Income Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.44% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 67.24% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.22% |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -26.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -26.00% |
| Dec 28, 2025 | -55.86% |
| Sep 28, 2025 | -26.74% |
| Jun 29, 2025 | -27.49% |
| Mar 30, 2025 | 27.65% |
| Dec 29, 2024 | 0.91% |
| Sep 29, 2024 | -63.46% |
| Jun 30, 2024 | -43.49% |
| Mar 31, 2024 | -31.69% |
| Oct 1, 2023 | -753.10% |
| Apr 2, 2023 | 2,116.85% |
| Jan 1, 2023 | 757.42% |
| Oct 2, 2022 | 574.30% |
| Jul 3, 2022 | 589.73% |
| Apr 3, 2022 | -457.60% |
| Jan 2, 2022 | 489.80% |
| Oct 3, 2021 | 163.18% |
| Jul 4, 2021 | 216.24% |
| Apr 4, 2021 | 851.24% |
| Jan 3, 2021 | 69.89% |